Cleveland Clinic pulmonologists address the role of measuring exhaled nitric oxide in the diagnosis and management of asthma and provide guidance for its appropriate use.Read More
Identifying specific and distinctive clinical phenotypes in COPD is beneficial in identifying pathogenetic mechanisms and prognosis of disease, as well as linking to specific therapies.
Discoveries uncover underlying mechanisms of fibrosis, opening the door to exciting new therapies for fibrotic disorders.
The director of Cleveland Clinic Children’s cystic fibrosis program opines on the merits and pitfalls of newborn screening, when to refer and the benefits of teaming with adult-care specialists.
Two long-awaited novel agents, pirfenidone and nintedanib, now FDA- approved for the treatment of idiopathic pulmonary fibrosis, provide hope and improve understanding and treatment of devastating fibrotic lung diseases.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Medicare now covers annual low-dose CT screenings for patients at greatest risk of developing lung cancer. This test can reduce lung cancer deaths in high-risk patients by 20 percent.
Rapamycin — an FDA-approved drug to prevent organ rejection in kidney transplant patients — is providing hope for patients affected by a rare lung disease that almost exclusively affects women.
Decisions about complex rheumatic conditions often must be based on expert opinions alone if RCTs aren’t available, especially when pulmonary disease is involved. Here’s how a combined rheumatology-pulmonary clinic can help.
Uncovering the nature, extent and significance of systemic vascular involvement in pulmonary arterial hypertension (PAH) may unlock a correlation to disease severity or response to therapy, leading to future treatment options
Cleveland Clinic research finds that chronic kidney disease is widely prevalent in patients with pulmonary hypertension, and that lower levels of kidney function are associated with an increased risk of death.
Functional magnetic stimulation can improve respiratory muscle conditioning and coughing in patients with chronic spinal cord injury. Now, Cleveland Clinic researchers are finding some value using it in MS patients.